The Valley Desk

Clinical trial reportAnnals of oncology : official journal of the European Society for Medical OncologyPublished

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Annals of oncology : official journal of the European Society for Medical Oncology
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Ipilimumab; Sunitinib
PubMed ID
41786248
Added to directory
Source checked

Report a correction or request removal